KAND Becomes One of the First Disorders Included in a New FDA-Funded Accelerator Program

Hello KIF1A.ORG Community, Want to know what’s more valuable than money? Data. In rare diseases, data are inherently difficult to collect and analyze. But we rely on data to inform everything from creating better care guidelines to discovering treatments and cures. We can’t treat what we don’t know. Which symptoms do patients experience, and why … Continue reading KAND Becomes One of the First Disorders Included in a New FDA-Funded Accelerator Program